FIELD: medicine, biotechnology, genetic engineering.
SUBSTANCE: invention proposes non-infectious for human adenovirus as a vector for substitution genetic therapy of angiogenesis disorders. This adenovirus is replicative-defect in mammalian cells (including humans) in region that is not essential for replication in avian cells and carries expression cassette consisting of cytomegalovirus promoter, human angiogenin gene cDNA and polyadenylation signal of bovine hormone growth, and provides induction of angiogenesis. Invention proposes a method for induction of angiogenesis and method for treatment of ischemic disease by using a composition comprising the proposed recombinant adenovirus. Invention can be used in medicine in treatment of cardiovascular diseases.
EFFECT: valuable medicinal properties of adenovirus and composition.
5 cl, 1 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARATION OF RECOMBINANT ADENOVIRUS OF BIRDS FOR VACCINATION AGAINST BIRDS FLU VIRUS H5N1 | 2006 |
|
RU2326943C1 |
METHOD OF PREPARATION OF RECOMBINANT BIRDS VIRUS FOR VACCINATION AND GENETIC THERAPY | 2007 |
|
RU2326942C1 |
RECOMBINANT PLASMID DNA (VARIANTS), METHOD FOR INDUCTION OF ANGIOGENESIS, METHOD FOR TREATMENT OF ISCHEMIC DISEASE AND COMPOSITION FOR ISCHEMIC DISEASE TREATMENT | 2001 |
|
RU2209245C2 |
METHOD OF INSERTION OF HETERODUPLEX DNA INTO GENOME OF ADENOVIRUS CELO AND RECOMBINANT ADENOVIRAL VECTOR CELO/PUC19 | 1992 |
|
RU2031122C1 |
METHOD OF OBTAINING PERORAL VACCINE AGAINST RABIES VIRUS | 2010 |
|
RU2432963C1 |
METHOD OF HUMAN RECOMBINANT LACTOFERRIN OBTAINING | 2007 |
|
RU2340674C1 |
METHOD OF ANGIOGENESIS AUGMENTATION IN ISCHEMIC TISSUES AND COMBINATION DRUG FOR METHOD IMPLEMENTATION | 2015 |
|
RU2628706C2 |
ACTIVE ANGIOGENESIS-PREVENTING IMMUNETHERAPY | 2003 |
|
RU2329824C2 |
RECOMBINANT PLASMID DNA PCVA FOR RIBOSIME EXPRESSION IN EUCARYOTIC CELL | 1995 |
|
RU2097429C1 |
RECOMBINANT PLASMID DNA pAP271 CODING HUMAN BLOOD COAGULABILITY FACTOR VII POLYPEPTIDE AND Mesocricetus auratus BHK 21 k. 13 (2H7) CELL LINE PRODUCER OF RECOMBINANT HUMAN BLOOD COAGULABILITY FACTOR VII | 2010 |
|
RU2448160C1 |
Authors
Dates
2008-04-10—Published
2005-06-24—Filed